Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | AC Immune SA | 25 |
| 2 | Roche Holding AG | 22 |
| 3 | Washington University in St. Louis | 14 |
| 4 | University of Washington | 9 |
| 5 | Sanofi SA | 7 |
| 6 | Denali Therapeutics Inc | 5 |
| 7 | Tenaya Therapeutics Inc | 5 |
| 8 | University of California | 5 |
| 9 | Genting Bhd | 4 |
| 10 | Alnylam Pharmaceuticals Inc | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 186 |
| 2 | A61K | Medicinal preparations | 178 |
| 3 | C07K | Peptides | 73 |
| 4 | G01N | Investigating / analysing materials | 68 |
| 5 | C07D | Heterocyclic compounds | 51 |
| 6 | A61B | 29 | |
| 7 | C12N | Microorganisms, enzymes | 26 |
| 8 | A23L | Foods and beverages (general) | 21 |
| 9 | G16H | Digital health, healthcare informatics | 21 |
| 10 | G06N | 17 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE | 2012 | 49 | |
| Phenothiazine diaminium salts and their use | 2016 | 27 | |
| Antibody-drug conjugates comprising anti-B7-H3 antibodies | 2023 | 5 | |
| ANTI-TAU MTBR ANTIBODIES AND METHODS TO DETECT CLEAVED FRAGMENTS OF TAU AND USES THEREOF | 2024 | Washington University in St. Louis | 3 |
| Administration and dosage of diaminophenothiazines | 2023 | 2 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Charles R. Harrington | University of Aberdeen | 14 |
| 2 | Claude M. Wischik | University of Aberdeen | 13 |
| 3 | Gernot Riedel | University of Aberdeen | 10 |
| 4 | John M. D. Storey | University of Aberdeen | 6 |
| 5 | Peter Bentham | TauRx (United Kingdom) | 5 |
| 6 | B. Schelter | University of Aberdeen | 5 |
| 7 | Serge Gauthier | Douglas Mental Health University Institute | 4 |
| 8 | Karin A. Kook | 4 | |
| 9 | Franz Theuring | Charité - Universitätsmedizin Berlin | 4 |
| 10 | Karima Schwab | Charité - Universitätsmedizin Berlin | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Methylene blue as an inhibitor of superoxide generation by xanthine oxidase | 1991 | 224 | Sulfur Compounds in Biology |
| Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial | 2017 | 220 | Dementia and Cognitive Impairment Research |
| Binding, Aggregation and Photochemical Properties of Methylene Blue in Mitochondrial Suspensions | 2004 | 165 | Nanoplatforms for cancer theranostics |
| Interactions of Methylene Blue with Human Disulfide Reductases and Their Orthologues fromPlasmodium falciparum | 2007 | 162 | Genomics, phytochemicals, and oxidative stress |
| A new assay method for lipid peroxides using a methylene blue derivative. | 1985 | 143 | Electrochemical sensors and biosensors |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Hydromethylthionine Mesylate?
Which organizations hold the most patents related to Hydromethylthionine Mesylate?
What is the current research activity trend for this compound?
Who are the most prolific authors publishing research on Hydromethylthionine Mesylate?
What are the primary patent classification areas for inventions related to Hydromethylthionine Mesylate?